سعر يوروكوكس 200مجم 10 اقراص 2024

Celecoxib 200 mg oral tablets, pack of 10.

• US celecoxib capsules are indicated for osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (2 years and older), ankylosing spondylitis, acute pain and primary dysmenorrhea.DailyMed (U.S. NLM)

• Most common adverse reactions in arthritis trials (more than 2% and more than placebo): abdominal pain, diarrhea, dyspepsia, flatulence, peripheral edema, accidental injury, dizziness, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection and rash.General active-ingredient information · DailyMed (U.S. NLM)

• Known hypersensitivity to celecoxib or any component; history of asthma, urticaria or other allergic-type reactions after aspirin or other NSAIDs; in the setting of CABG surgery; known allergy to sulfonamides.General active-ingredient information · DailyMed (U.S. NLM)

• Boxed warning: NSAIDs increase the risk of serious cardiovascular thrombotic events (myocardial infarction, stroke), which may be fatal and may occur early in treatment; contraindicated in the setting of CABG surgery. NSAIDs increase the risk of serious gastrointestinal bleeding, ulceration and perforation, which can be fatal; elderly patients and those with prior peptic ulcer or GI bleeding are at greater risk.General active-ingredient information · DailyMed (U.S. NLM)
• Hepatotoxicity, hypertension, heart failure and edema, renal toxicity and hyperkalemia, anaphylactic reactions, exacerbation of aspirin-sensitive asthma, serious skin reactions, DRESS, fetal toxicity (avoid from about 30 weeks; oligohydramnios from about 20 weeks), hematologic toxicity.General active-ingredient information · DailyMed (U.S. NLM)

• Anticoagulants (e.g. warfarin), antiplatelets, SSRIs/SNRIsIncreased risk of bleeding; monitor patients.DailyMed (U.S. NLM)
• ACE inhibitors, ARBs, beta-blockers, diureticsNSAIDs may diminish antihypertensive and natriuretic effects and increase the risk of renal impairment.DailyMed (U.S. NLM)
• Lithium, methotrexate, cyclosporine, digoxinNSAIDs may increase concentrations or toxicity; monitor.DailyMed (U.S. NLM)

• Use of NSAIDs at about 30 weeks gestation and later increases the risk of premature closure of the fetal ductus arteriosus; use at about 20 weeks or later has been associated with fetal renal dysfunction leading to oligohydramnios; avoid from 30 weeks and limit use between 20 and 30 weeks.General active-ingredient information · DailyMed (U.S. NLM)
• Limited data indicate celecoxib is present in human milk at low levels; consider the benefits of breastfeeding and the mother's need for treatment.General active-ingredient information · DailyMed (U.S. NLM)

• Celecoxib: Inhibits prostaglandin synthesis primarily via inhibition of cyclooxygenase-2 (COX-2) (US Celebrex label).